Holthof, Lisa C <br/><br/>
Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma.  [electronic resource] 

 -  Haematologica  2020 
 - e80-e83 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2018.213314  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzodioxoles<br/>Humans<br/>Indolizines<br/>Multiple Myeloma--drug therapy<br/>Survivin--antagonists & inhibitors